Segal Cancer Centre, Jewish General Hospital, McGill University
Academic institution

Montreal
Quebec, Canada


Segal scientists conduct research in molecular oncology, cancer prevention/genetics, biomarkers, and other new cancer therapies
The Segal Cancer Centre is a state-of-the-art facility which provides patients with the most comprehensive approach to care, combining cancer prevention, diagnosis, treatment, psychosocial support, nutritional support and clinical and fundamental research in cancer.

The Segal Cancer Centre has thriving cancer research programs focusing on fundamental, translational, clinical, nursing, psychosocial and palliative care research. Clinician scientists and basic researchers conduct research in molecular oncology, cancer prevention/cancer genetics, biomarkers in cancer therapy, new cancer therapies and radiopharmaceutical chemistry/ radiobiology, with a focus on general cancer or specific cancers such as breast, ovarian, prostate or leukemia.

Represented by:

Alan Spatz logotype
Alan Spatz

Chief, Department of Clinical Laboratory Medicine and Medical Director, MUHC & Professor of Pathology & Oncology, McGill University (Canada)

Gerald Batist logotype
Gerald Batist

Director, Segal Cancer Centre, Sir Mortimer B. Davis-Jewish General Hospital (Canada)